Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China

AIDS

Volumn 21, Issue SUPPL. 8, 2007, Pages

  Wang, Xiaoqi ^a,b   Wu, Zunyou ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Adherence; AIDS; Antiretroviral therapy; China; HIV; Rural health

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CHINA; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; EDUCATION PROGRAM; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SKILL; TRAINING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANTI-HIV AGENTS; CHINA; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PREJUDICE; REMINDER SYSTEMS; RURAL POPULATION; SOCIOECONOMIC FACTORS;

EID: 37549041652     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000304711.87164.99     Document Type: Article

References (24)

1. Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA 2000; 283:205-211.
2. Murri R, Ammassari A, Gallicano K, De Luca A, Cingolani A, Jacobson D, et al. Patient-reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immune Defic Syndr 2000; 24:123-128.
3. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000; 15:386-395.
4. Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS 1999; 13:1099-1107.
5. Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14:357-366.
6. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30.
7. Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS 2004; 18:1393-1401.
8. Zhang FJ, Au M, Haberer J, Zhao Y. Overview of HIV drug resistance and its implications for China. Chinese Medical Journal 2006; 119:1999-2004.
9. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
10. Pinheiro CA, de-Carvalho-Leite JC, Drachler ML, Silveira VL. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: a cross-sectional study in Southern Brazil. Brazil J Med Biol Res 2002; 35:1173-1181.
11. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquire Immune Defic Synd 2003; 34:281-288.
12. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Topics in HIV Medicine 2003; 11:185-198.
13. China Ministry of Health and UN Theme Group on HIV/AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China. Beijing: Technical Report; 2004. Available at: http://www.chinaaids.cn/worknet/ download/2004/report2004en.pdf. Accessed: March 2005.
14. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. ACTG Adherence baseline and follow up questionnaire. AIDS Clinical Trials Group (ACTG) Recruitment. Adherence and Retention Subcommittee. Available at: http://www.caps.ucsf.edu/tools/surveys/#8. Accessed: October 2004.
15. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis 2000; 30 (Suppl 2):171-176.
16. Ammassari A, Murri R, Pezzotti P, Trotta MP, Ravasio L, De Longis P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001; 28:445-449.
17. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M, Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 2001; 13:27-40.
18. Chesney MA. Compliance: How You Can Help. Available at: http://www.thebody.com/hivnews/newsline/june97/comply.html. Accessed: December 2005.
19. Turner BJ. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis 2002; 185 (Suppl 2):S143-S151.
20. Stone VE. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practices. Clin Infect Dis 2001; 33:865-872.
21. Monforte AD, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. AIDS 2000; 14:499-507.
22. Chesney MA, Ickovics J, Hecht FM, Skipa C, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999; 13:S1-S8.
23. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000; 23:386-389.
24. Wu XW, Wu GJ. Adherence measurement among senior inpatients (in Chinese). Chin Med J Commun 2003; 17:512-513.